DHODH and rheumatoid arthritis: Leflunomide is an approved drug for treatment of rheumatoid arthritis and its principle mode of action is inhibition of DHODH and mitochondria-based synthesis of pyrimidines, one of two pathways that typically supply pyrimidines to cells.